# Pliant Therapeutics, Inc.: Form 8-K, filed Jul 2, 2021

- Company: [Pliant Therapeutics, Inc.](/companies/plrx.md) (CIK 1746473)
- Form: 8-K
- Filed: 2021-07-02
- Accepted by EDGAR: Jul 2, 2021, 10:17 ET
- Period: 2021-06-29
- Accession: 0001746473-21-000011
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1746473/000174647321000011/plrx-8k2021agmresults.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1746473/000174647321000011/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1746473/000174647321000011/plrx-8k2021agmresults.htm

Filed Jul 2, 2021.
Source: SEC EDGAR, the filing index for accession 0001746473-21-000011. Last ingested by Listed: Nov 13, 2026, 15:38 ET. No prices; not investment advice.
